Defining the Critical Components of Informed Consent for Genetic Testing
Kelly E. Ormond(Stanford University), Curtis R. Coughlin(University of Colorado Denver), W. Andrew Faucett(Geisinger Medical Center), Wendy R. Uhlmann(University of Michigan), Maureen E. Smith(Northwestern University), Eric P. Tricou(Stanford University), Maia J. Borensztein(Stanford University), Miranda L. G. Hallquist, Karen E. Wain(Geisinger Medical Center), Adam H. Buchanan(Geisinger Health System), Holly L. Peay(RTI International)
Cited by 40
Related Papers
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
|Genetics in Medicine|2013|741
Recommendations for returning genomic incidental findings? We need to talk!
|Genetics in Medicine|2013|288
Public and Biobank Participant Attitudes toward Genetic Research Participation and Data Sharing
|Public Health Genomics|2010|274
A systematic literature review of individuals’ perspectives on broad consent and data sharing in the United States
|Genetics in Medicine|2015|264